# Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency Anemia

> **NCT00704353** · PHASE3 · COMPLETED · sponsor: **American Regent, Inc.** · enrollment: 735 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** Ferric Carboxymaltose
- **DRUG:** Standard Medical Care (SMC)

## Key facts

- **NCT ID:** NCT00704353
- **Lead sponsor:** American Regent, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-07
- **Final completion:** 2011-03
- **Target enrollment:** 735 (ACTUAL)
- **Last updated:** 2018-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00704353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00704353, "Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency Anemia". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT00704353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*